These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24964990)

  • 21. An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys.
    Geisbert JB; Borisevich V; Prasad AN; Agans KN; Foster SL; Deer DJ; Cross RW; Mire CE; Geisbert TW; Fenton KA
    J Infect Dis; 2020 May; 221(Suppl 4):S414-S418. PubMed ID: 31665362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral immune response in the African green monkey model following Nipah-Malaysia virus exposure by intermediate-size particle aerosol.
    Lara A; Cong Y; Jahrling PB; Mednikov M; Postnikova E; Yu S; Munster V; Holbrook MR
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007454. PubMed ID: 31166946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.
    Pickering BS; Hardham JM; Smith G; Weingartl ET; Dominowski PJ; Foss DL; Mwangi D; Broder CC; Roth JA; Weingartl HM
    Vaccine; 2016 Sep; 34(40):4777-86. PubMed ID: 27544586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody prophylaxis and therapy against Nipah virus infection in hamsters.
    Guillaume V; Contamin H; Loth P; Grosjean I; Courbot MC; Deubel V; Buckland R; Wild TF
    J Virol; 2006 Feb; 80(4):1972-8. PubMed ID: 16439553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A neutralization test for specific detection of Nipah virus antibodies using pseudotyped vesicular stomatitis virus expressing green fluorescent protein.
    Kaku Y; Noguchi A; Marsh GA; McEachern JA; Okutani A; Hotta K; Bazartseren B; Fukushi S; Broder CC; Yamada A; Inoue S; Wang LF
    J Virol Methods; 2009 Sep; 160(1-2):7-13. PubMed ID: 19433112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the immunogenicity of an mRNA vectored Nipah virus vaccine candidate in pigs.
    Pedrera M; McLean RK; Medfai L; Thakur N; Todd S; Marsh G; Bailey D; Donofrio G; Muramatsu H; Pardi N; Weissman D; Graham SP
    Front Immunol; 2024; 15():1384417. PubMed ID: 38726013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.
    Zhu Z; Dimitrov AS; Bossart KN; Crameri G; Bishop KA; Choudhry V; Mungall BA; Feng YR; Choudhary A; Zhang MY; Feng Y; Wang LF; Xiao X; Eaton BT; Broder CC; Dimitrov DS
    J Virol; 2006 Jan; 80(2):891-9. PubMed ID: 16378991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine.
    Mungall BA; Middleton D; Crameri G; Bingham J; Halpin K; Russell G; Green D; McEachern J; Pritchard LI; Eaton BT; Wang LF; Bossart KN; Broder CC
    J Virol; 2006 Dec; 80(24):12293-302. PubMed ID: 17005664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody.
    Xu K; Rockx B; Xie Y; DeBuysscher BL; Fusco DL; Zhu Z; Chan YP; Xu Y; Luu T; Cer RZ; Feldmann H; Mokashi V; Dimitrov DS; Bishop-Lilly KA; Broder CC; Nikolov DB
    PLoS Pathog; 2013; 9(10):e1003684. PubMed ID: 24130486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice.
    Li Y; Li R; Wang M; Liu Y; Yin Y; Zai X; Song X; Chen Y; Xu J; Chen W
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32340278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute Hendra virus infection: Analysis of the pathogenesis and passive antibody protection in the hamster model.
    Guillaume V; Wong KT; Looi RY; Georges-Courbot MC; Barrot L; Buckland R; Wild TF; Horvat B
    Virology; 2009 May; 387(2):459-65. PubMed ID: 19328514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs.
    Kong D; Wen Z; Su H; Ge J; Chen W; Wang X; Wu C; Yang C; Chen H; Bu Z
    Virology; 2012 Oct; 432(2):327-35. PubMed ID: 22726244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months.
    Pallister JA; Klein R; Arkinstall R; Haining J; Long F; White JR; Payne J; Feng YR; Wang LF; Broder CC; Middleton D
    Virol J; 2013 Jul; 10():237. PubMed ID: 23867060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction of the safe neutralizing assay system using pseudotyped Nipah virus and G protein-specific monoclonal antibody.
    Bae SE; Kim SS; Moon ST; Cho YD; Lee H; Lee JY; Shin HY; Lee HJ; Kim YB
    Biochem Biophys Res Commun; 2019 Jun; 513(4):781-786. PubMed ID: 30995971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in diagnostics, vaccines and therapeutics for Nipah virus.
    Thakur N; Bailey D
    Microbes Infect; 2019; 21(7):278-286. PubMed ID: 30817995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets.
    Satterfield BA; Cross RW; Fenton KA; Borisevich V; Agans KN; Deer DJ; Graber J; Basler CF; Geisbert TW; Mire CE
    J Virol; 2016 Jul; 90(14):6326-6343. PubMed ID: 27147733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity.
    Prasad AN; Woolsey C; Geisbert JB; Agans KN; Borisevich V; Deer DJ; Mire CE; Cross RW; Fenton KA; Broder CC; Geisbert TW
    J Infect Dis; 2020 May; 221(Suppl 4):S436-S447. PubMed ID: 32022850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type I interferon signaling protects mice from lethal henipavirus infection.
    Dhondt KP; Mathieu C; Chalons M; Reynaud JM; Vallve A; Raoul H; Horvat B
    J Infect Dis; 2013 Jan; 207(1):142-51. PubMed ID: 23089589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant vesicular stomatitis virus-vectored vaccine induces long-lasting immunity against Nipah virus disease.
    Woolsey C; Borisevich V; Fears AC; Agans KN; Deer DJ; Prasad AN; O'Toole R; Foster SL; Dobias NS; Geisbert JB; Fenton KA; Cross RW; Geisbert TW
    J Clin Invest; 2023 Feb; 133(3):. PubMed ID: 36445779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein.
    Doyle MP; Kose N; Borisevich V; Binshtein E; Amaya M; Nagel M; Annand EJ; Armstrong E; Bombardi R; Dong J; Schey KL; Broder CC; Zeitlin L; Kuang EA; Bornholdt ZA; West BR; Geisbert TW; Cross RW; Crowe JE
    Cell Rep; 2021 Aug; 36(9):109628. PubMed ID: 34469726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.